AP2006003759A0 - (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazoloÄ1,5-cÜÄ1,3Übenzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors - Google Patents

(1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazoloÄ1,5-cÜÄ1,3Übenzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors

Info

Publication number
AP2006003759A0
AP2006003759A0 AP2006003759A AP2006003759A AP2006003759A0 AP 2006003759 A0 AP2006003759 A0 AP 2006003759A0 AP 2006003759 A AP2006003759 A AP 2006003759A AP 2006003759 A AP2006003759 A AP 2006003759A AP 2006003759 A0 AP2006003759 A0 AP 2006003759A0
Authority
AP
ARIPO
Prior art keywords
phenyl
cüä1
aminocarbonyl
dihydro
viral replication
Prior art date
Application number
AP2006003759A
Other languages
English (en)
Inventor
Abdellah Tahri
Lieve Emma Jan Michiels
Dominique Louis Nest Surleraux
Van Koenraad Lodewijk Au Acker
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of AP2006003759A0 publication Critical patent/AP2006003759A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AP2006003759A 2004-05-04 2005-05-04 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazoloÄ1,5-cÜÄ1,3Übenzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors AP2006003759A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04101913 2004-05-04
US60427504P 2004-08-25 2004-08-25
PCT/EP2005/052041 WO2005105810A2 (en) 2004-05-04 2005-05-04 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors

Publications (1)

Publication Number Publication Date
AP2006003759A0 true AP2006003759A0 (en) 2006-10-31

Family

ID=35058129

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003759A AP2006003759A0 (en) 2004-05-04 2005-05-04 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazoloÄ1,5-cÜÄ1,3Übenzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors

Country Status (20)

Country Link
US (1) US7326703B2 (no)
EP (1) EP1778696B1 (no)
JP (1) JP4929162B2 (no)
KR (1) KR20070015547A (no)
CN (1) CN1950380B (no)
AP (1) AP2006003759A0 (no)
AR (1) AR048650A1 (no)
AT (1) ATE389660T1 (no)
AU (1) AU2005238235B2 (no)
BR (1) BRPI0510612A (no)
CA (1) CA2563959C (no)
DE (1) DE602005005490T2 (no)
ES (1) ES2303244T3 (no)
IL (1) IL178082A (no)
MX (1) MXPA06012755A (no)
NO (1) NO20065582L (no)
PL (1) PL1778696T3 (no)
RU (1) RU2382789C2 (no)
WO (1) WO2005105810A2 (no)
ZA (1) ZA200609178B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122185B2 (en) 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
TW200710091A (en) * 2005-04-11 2007-03-16 Tibotec Pharm Ltd (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
CA2616189C (en) * 2005-07-22 2019-03-26 Progenics Pharmaceuticals, Inc. Methods for reducing viral load in hiv-1-infected patients
RU2010102067A (ru) * 2007-06-25 2011-07-27 Тиботек Фармасьютикалз (Ie) Комбинированные композиции, включающие дарунавир и этравирин
US8592487B2 (en) * 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
WO2009134401A2 (en) * 2008-04-29 2009-11-05 Progenics Pharmaceuticals, Inc. Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE4210939A1 (de) * 1992-04-02 1993-10-07 Bayer Ag Verwendung von 7-Oxo-7H-pyrido[1,2,3-de][1,4]benzoxacin-6-carbonsäuren und -estern als Arzneimittel
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
DK0721331T3 (da) 1993-10-01 2002-02-11 Astrazeneca Ab Fremgangsmåde
EE03902B1 (et) 1996-05-20 2002-12-16 Janssen Pharmaceutica N.V. Osakesed, nende valmistamismeetod ja kasutamine, farmatseutiline doseerimisvorm ja selle valmistamismeetod, tahke dispersioon ning farmatseutiline pakend
CA2268953A1 (en) 1996-10-02 1998-04-09 Du Pont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
ATE241969T1 (de) 1997-03-26 2003-06-15 Janssen Pharmaceutica Nv Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist
CZ289425B6 (cs) * 1998-05-20 2002-01-16 Eli Lilly And Company Imidazo[1,2-a] pyridinové sloučeniny, jejich pouľití a farmaceutický přípravek s jejich obsahem
EE05400B1 (et) * 2001-04-10 2011-04-15 Pfizer Inc. Prasoolderivaadid, neid v?i nende farmatseutiliselt vastuv?etavaid sooli, solvaate v?i derivaate sisaldavad farmatseutilised kompositsioonid, nende kasutamine ning meetodid nende valmistamiseks

Also Published As

Publication number Publication date
MXPA06012755A (es) 2007-01-16
EP1778696B1 (en) 2008-03-19
JP4929162B2 (ja) 2012-05-09
ES2303244T3 (es) 2008-08-01
IL178082A (en) 2012-06-28
IL178082A0 (en) 2006-12-31
US7326703B2 (en) 2008-02-05
RU2382789C2 (ru) 2010-02-27
CA2563959A1 (en) 2005-11-10
US20070248624A1 (en) 2007-10-25
DE602005005490D1 (de) 2008-04-30
AR048650A1 (es) 2006-05-10
PL1778696T3 (pl) 2008-08-29
JP2007536346A (ja) 2007-12-13
EP1778696A2 (en) 2007-05-02
CN1950380A (zh) 2007-04-18
DE602005005490T2 (de) 2009-04-23
CA2563959C (en) 2014-07-15
ATE389660T1 (de) 2008-04-15
AU2005238235A1 (en) 2005-11-10
AU2005238235B2 (en) 2011-07-07
RU2006142705A (ru) 2008-06-20
CN1950380B (zh) 2010-12-08
WO2005105810A3 (en) 2006-03-02
NO20065582L (no) 2006-12-04
WO2005105810A2 (en) 2005-11-10
ZA200609178B (en) 2008-08-27
KR20070015547A (ko) 2007-02-05
BRPI0510612A (pt) 2007-10-30

Similar Documents

Publication Publication Date Title
IL183706A0 (en) 2,4(4,6) pyrimidine derivatives
HK1209729A1 (en) Compounds, compositions and methods
AP2005003452A0 (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors.
AP2005003353A0 (en) Diazepinoindole derivatives as kinase inhibitors.
DK1711494T3 (da) Arylsubstituerede heterocykler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
IL177798A0 (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
EP2223921B8 (en) 2-Thiophen-2-yl-oxazole, 2-Thiophen-2-yl-thiazole and 2-Thiophen-2-yl-1H-imidazole derivatives as antiviral agents
IL191711A0 (en) 1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as ptp-as inhibitors
TW200724540A (en) Heterocyclic antiviral compounds
GB0419481D0 (en) Isoindolin-1-one derivatives
IL192298A (en) Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
HK1080843A1 (en) (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
WO2008127364A3 (en) Antiviral compounds and use thereof
EP1773846A4 (en) INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE (IDO)
AP2006003659A0 (en) Azabenzofuran substituted thioureas, inhibitors ofviral replication
ZA200805028B (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
AP2006003759A0 (en) (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazoloÄ1,5-cÜÄ1,3Übenzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
IL182739A0 (en) Acylatednonadepsipeptides used as lysobactin derivatives
HK1104823A1 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
EP1797077A4 (en) BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND APPLICATIONS THEREOF
EP1874116A4 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INHIBITING HIV INFECTIOUSITY
DE602005017152D1 (de) Neue 2,6-diaminopyridin-3-on-derivate
IL182538A0 (en) 1,5-diheterocycle-1h-triazole derivative
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
EP1711189A4 (en) AZALIDE DERIVATIVES 8A 6,11-3C-BICYCLIC